Opioid Agonists and Antagonists

Aug 14, 2016 by in PHARMACY Comments Off on Opioid Agonists and Antagonists

II.  Chemical Structure of Opium Alkaloids. The active components of opium can be divided into two distinct chemical classes: phenanthrenes and benzylisoquinolines. The principal phenanthrene alkaloids present in opium are morphine,…

read more

Drugs that Alter Glucose Regulation

Aug 14, 2016 by in PHARMACY Comments Off on Drugs that Alter Glucose Regulation

A.  Diabetes mellitus is classified by the underlying disease etiology (type 1 vs. type 2) rather than by age-of-onset (juvenile-onset vs. adult-onset diabetes) or treatment modality (insulin-dependent vs. non–insulin-dependent diabetes).   1.  The…

read more

Blood Products and Blood Components

Aug 14, 2016 by in PHARMACY Comments Off on Blood Products and Blood Components

II.  Transfusion Therapy for Bleeding. Critical bleeding in the perioperative setting requires volume replacement (crystalloid, colloid, red blood cells [RBCs]) (none provide coagulation factors or platelets and thus their use can…

read more

Antiepileptic and Other Neurologically Active Drugs

Aug 14, 2016 by in PHARMACY Comments Off on Antiepileptic and Other Neurologically Active Drugs

A.  Pharmacokinetics (see Table 13-4)   1.  All antiepileptic drugs are administered once daily or more frequently.   2.  Because of their ability to induce or inhibit drug metabolism, all antiepileptic drugs (except gabapentin, levetiracetam,…

read more

Physiology of Blood and Hemostasis

Aug 14, 2016 by in PHARMACY Comments Off on Physiology of Blood and Hemostasis

II.  Hemostasis and History (see Figs. 27-1 and 27-2) (Table 27-1) A.  Initiation of Coagulation. Initiation of coagulation by procoagulant activities has been traditionally separated into extrinsic, intrinsic, and common pathways (a…

read more

Antiarrhythmic Drugs

Aug 14, 2016 by in PHARMACY Comments Off on Antiarrhythmic Drugs

B.  The effects of cardiac antiarrhythmic drugs on the action potential and effective refractory period of the cardiac action potential determine the clinical effect of these drugs. III.  Classification A.  Cardiac arrhythmic drugs…

read more

Lipid-Lowering Drugs

Aug 14, 2016 by in PHARMACY Comments Off on Lipid-Lowering Drugs

II.  Lipid Disorders A.  Familial hypercholesterolemia arises from a defect in the gene for low-density lipoprotein receptors (LDL-R). Heterozygotes for this defect experience accelerated atherosclerosis and represent about 1 in 500 persons….

read more

Physiology and Management of Massive Transfusion

Aug 14, 2016 by in PHARMACY Comments Off on Physiology and Management of Massive Transfusion

B.  Plasma/fresh frozen plasma contains multiple factors for hemostasis and has increasingly been considered a critical component (see Fig. 31-1). C.  Platelet Administration   1.  Following traumatic injury or significant postoperative bleeding, the critical…

read more

Neuromuscular Blocking Drugs and Reversal Agents

Aug 14, 2016 by in PHARMACY Comments Off on Neuromuscular Blocking Drugs and Reversal Agents

B.  Depolarizing neuromuscular block (also called phase I block) is often preceded by muscle fasciculation. During partial neuromuscular block, depolarizing block is characterized by (a) decrease in twitch tension, (b) no…

read more
Get Clinical Tree app for offline access